| 15/08/07
                    
                     The first all-African genetically modified crop plant
                      with resistance to the severe maize streak virus (MSV),
                      which seriously reduces the continent’s maize yield,
                      has been developed by scientists from the University of
                      Cape Town and PANNAR PTY Ltd, a South African seed company.
                     
                      
					  Maize streak virus symptoms in a commercial maize field in Klerksdorp, NorthWest South Africa, showing chlorotic streaking and deformed cob development. This farm grew USA commercial hybrids and experienced almost total yield losses. Photograph taken in April 2005 by Dr F. Kloppers.                       
                       
                                          
                          | 
                       
                     
                    The research, published in Plant
                        Biotechnology Journal                      represents a significant advance in African agricultural
                      biotechnology, and will play an important role in alleviating
                      Africa’s food shortages and famine. 
                     
                    Dr Dionne Shepherd, lead researcher explains, “MSV
                      is transmitted to maize by small insects called leafhoppers.
                      The disease is therefore a result of a complex interplay
                      between the plant, the virus and insect. Factors that can
                      influence the severity of the disease include the age at
                      which the plant is infected (the younger the plant, the
                      more severe the infection), the maize variety (some are
                      more susceptible than others), and environmental conditions. 
                     
                    “We have created an MSV-resistant maize variety
                      by genetic engineering, using an approach known as pathogen-derived
                      resistance. This means that a gene from the viral pathogen
                      is used to protect the plant from that pathogen. We mutated
                      a viral gene that under normal circumstances produces a
                      protein that is essential for the virus to replicate itself
                      and inserted it into the maize plant’s genome, creating
                      genetically modified maize. When the virus infects one
                      of these transgenic maize plants, it displays a significant
                      delay in symptom development, a decrease in symptom severity
                      and higher survival rates than non-transgenic plants.” 
                     
                    The next stage of the research involves field trials to
                      ensure that the transformed crop is digestible, that the
                      protein is not an allergen and that it will be ecologically
                      friendly to other organisms within the environment. Following
                      the results of these trials, the crop will be monitored
                      over a number of growing seasons before it is made accessible
                      to local farmers. 
              Summer Rains Increase Risk of Mould and Toxin Contamination Warns Agil 
  Farmer Gets Lost in His Own Maize Maze 
  Grain Treatment Cuts Drying Costs and Boosts Feed Value 
  Crop
Market Update             |